2015
DOI: 10.4088/jcp.14com09522
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacotherapy for Borderline Patients: Business as Usual or by Default?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 8 publications
1
11
0
Order By: Relevance
“…Five major treatments—DBT, mentalization-based treatment (MBT) [ 1 ], schema-focused therapy (SFT) [ 2 ], transference-focused psychotherapy (TFP) [ 3 ], and systems training for emotional predictability and problem solving (STEPPS) [ 4 ]—have been established as evidence based treatments (EBTs) for BPD [ 5 ]. In contrast, trials testing psychopharmacologic treatments have not yielded consistent results [ 6 , 7 ]; therefore, to date no medication has an official indication for BPD [ 8 •]. This review will summarize major findings of what works in treatments for BPD, with a special emphasis on developments in the last 5 years.…”
Section: Introductionmentioning
confidence: 99%
“…Five major treatments—DBT, mentalization-based treatment (MBT) [ 1 ], schema-focused therapy (SFT) [ 2 ], transference-focused psychotherapy (TFP) [ 3 ], and systems training for emotional predictability and problem solving (STEPPS) [ 4 ]—have been established as evidence based treatments (EBTs) for BPD [ 5 ]. In contrast, trials testing psychopharmacologic treatments have not yielded consistent results [ 6 , 7 ]; therefore, to date no medication has an official indication for BPD [ 8 •]. This review will summarize major findings of what works in treatments for BPD, with a special emphasis on developments in the last 5 years.…”
Section: Introductionmentioning
confidence: 99%
“…There is increasing interest in the scientific community about the underlying biological processes and mechanisms that lead to the manifestation of personality disorders. For example, regarding borderline personality disorder, it has been noticed that although international guidelines recommend pharmacotherapy for comorbid psychiatric disorders whenever necessary, 82% of the UK borderline personality disorder patients without such comorbid conditions nevertheless receive drugs, mostly offlabel [9]. Therefore, there is the risk that borderline patients become at the mercy of preference of individual psychiatrists.…”
Section: Discussionmentioning
confidence: 99%
“…This means that there is an urgent need of serious systematic reviews and meta-analyses of available randomized controlled trials. To date, we have to rely on the current, limited, and controversial database with respect to efficacy and tolerability [9]. When medication is not reviewed, it is not possible to determine if the benefits of treatment outweigh the risks, and patients with personality disorders may be exposed to possible side effects.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Obviously, comorbidity does not account for the high use of medication in BPD. Despite the complete lack of reliable, supporting evidence, be it from meta-analytically accumulated evidence or at least single RCTs, antidepressants are still prescribed "by default", it seems [30].…”
Section: Ongoing Rctsmentioning
confidence: 99%